Data / Form D filings / TopoDx, Inc.
TopoDx, Inc.: Form D filings
TopoDx, Inc., a biotechnology company in Atlanta, GA, filed 2 Form D notices with the SEC in 2025. The latest, on September 5, 2025, reports $1.5 million sold of a $2 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 NEREM ST. NW, SUITE 1000, Atlanta, GA, 30313
- Phone
- (828) 291-6715
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Georgia
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2075590
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | Amendment | $2,000,000 | $1,500,000 | $500,000 | 10 | Jul 14, 2025 | sec.gov |
| Jul 15, 2025 | New notice | $2,000,000 | $1,125,000 | $875,000 | 6 | Jul 14, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Yunker | Director | |
| David Weiss | Director | |
| Yogi Patel | Executive Officer, Director |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Sep 1, 2025 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TopoDx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.